Literature DB >> 11114718

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.

D Sinibaldi1, W Wharton, J Turkson, T Bowman, W J Pledger, R Jove.   

Abstract

While the activated viral Src oncoprotein, v-Src, induces uncontrolled cell growth, the mechanisms underlying cell cycle deregulation by v-Src have not been fully defined. Previous studies demonstrated that v-Src induces constitutively active STAT3 signaling that is required for cell transformation and recent data have implicated STAT3 in the transcriptional control of critical cell cycle regulators. Here we show in mouse fibroblasts stably transformed by v-Src that mRNA and protein levels of p21 (WAF1/CIP1), cyclin D1, and cyclin E are elevated. Using reporter constructs in transient-transfection assays, the cyclin D1 and p21 promoters were both found to be transcriptionaly induced by v-Src in a STAT3-dependent manner. The kinase activities of cyclin D/CDK4, 6 and cyclin E/CDK2 complexes were only slightly elevated, consistent with the findings that coordinate increases in p21, cyclin D1 and cyclin E resulted in an increase in cyclin/CDK/p21 complexes. Similar results were obtained in NIH3T3 and BALB/c 3T3 cells stably transformed by v-Src, indicating that these regulatory events associated with STAT3 signaling represent common mechanisms independent of cell line or clonal variation. These findings suggest that STAT3 has an essential role in the regulation of critical cell cycle components in v-Src transformed mouse fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114718     DOI: 10.1038/sj.onc.1203947

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  92 in total

Review 1.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

2.  RACK1 regulates G1/S progression by suppressing Src kinase activity.

Authors:  Vidya Mamidipudi; Jian Zhang; Kelly C Lee; Christine A Cartwright
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 3.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

4.  Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells.

Authors:  Vidya Mamidipudi; Laura D Miller; Daria Mochly-Rosen; Christine A Cartwright
Journal:  Biochem Biophys Res Commun       Date:  2006-11-15       Impact factor: 3.575

5.  SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.

Authors:  Jie Zhang; Shailaja Kalyankrishna; Marie Wislez; Nishan Thilaganathan; Babita Saigal; Wei Wei; Long Ma; Ignacio I Wistuba; Faye M Johnson; Jonathan M Kurie
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

6.  ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.

Authors:  Valerie S Hawthorne; Wen-Chien Huang; Christopher L Neal; Ling-Min Tseng; Mien-Chie Hung; Dihua Yu
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

7.  Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.

Authors:  Amir Sonnenblick; Carmit Levy; Ehud Razin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies.

Authors:  Ariane Nadia Backes; Ana Cristina Aoun Tannuri; Fabiane Neiva Backes; Amadeu Jose Rodrigues Queiroz; Maria Cecília Mendonça Coelho; Elenice Lima da Silva; Evandro Sobroza de Mello; Uenis Tannuri
Journal:  Pediatr Surg Int       Date:  2014-04       Impact factor: 1.827

9.  Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes.

Authors:  Chi Tarn; Lin Zou; Ronald L Hullinger; Ourania M Andrisani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination.

Authors:  Joo Eun Jung; Hong Sook Kim; Chang Seok Lee; Yong Jae Shin; Yong Nyun Kim; Gyeong Hoon Kang; Tae You Kim; Yong Sung Juhnn; Sung Joon Kim; Jong Wan Park; Sang Kyu Ye; Myung Hee Chung
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.